Image pharmaphorum Editor Patients 2021 in review: Building the framework of a patient-centric ... Patient centricity and patient engagement have been hot topics in pharma for some time – but buzz words do not always translate into concrete action. R&D Drug development and working with specialised Rare Disease n... There are currently an estimated 300 million people living with one or more Rare Diseases across the world. News Frontiers Health 2021 Spotlight Digital Frontiers Health Digital Innovators: Aptar’s Sai Shankar Continuing his Frontiers Health Digital Innovator's series, pharmaphorum’s founder, Dr Paul Tunnah, speaks with president of Digital Health Sai Shankar. At Frontiers Health Load more results
Patients 2021 in review: Building the framework of a patient-centric ... Patient centricity and patient engagement have been hot topics in pharma for some time – but buzz words do not always translate into concrete action.
R&D Drug development and working with specialised Rare Disease n... There are currently an estimated 300 million people living with one or more Rare Diseases across the world.
Digital Frontiers Health Digital Innovators: Aptar’s Sai Shankar Continuing his Frontiers Health Digital Innovator's series, pharmaphorum’s founder, Dr Paul Tunnah, speaks with president of Digital Health Sai Shankar. At Frontiers Health
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
